Printer Friendly

Deal snapshot: IVF BIOSCIENCE ACQUIRES INTELLECTUAL PROPERTY FROM EMBRYOTRANS BIOTECH.

MANews-(C)2009-2015

UK-based in-vitro fertilisation specialist IVF Bioscience has acquired EmbryoTrans Biotech's intellectual property for the production of IVF media for animal species used during the in-vitro fertilisation process. The transaction value has not been disclosed, the company said.

IVF Bioscience will launch their first species specific media with the Bovine BO-IVF range. EmbryoTrans Biotech will continue to develop new products for IVF Bioscience under an exclusive agreement.

Country: UK

Sector: Biotechnology

Target: EmbryoTrans Biotech intellectual property for the production of IVF media

Buyer: IVF Bioscience

Vendor: EmbryoTrans Biotech

Deal size in USD:

Type: Corporate Acquisition

Financing:

Status: Closed

Buyer advisor: , ,

Comment: Terms of the deal were not disclosed

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Sep 23, 2015
Words:110
Previous Article:Deal snapshot: MOZIDO CLOSES ACQUISITION OF MOBILE COMMERCE FIRM CORFIRE.
Next Article:Deal snapshot: CENTENE FILES DEFINITIVE PROXY STATEMENT/PROSPECTUS, SETS DATE FOR SPECIAL MEETING.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters